Repetitive nerve stimulation and single-fibre electromyography: a biomarker of response to eculizumab in refractory myasthenia gravis?

Neurol Sci. 2024 Nov;45(11):5551-5554. doi: 10.1007/s10072-024-07663-w. Epub 2024 Jun 26.

Authors

Andrea Rigamonti¹, Vittorio Mantero², Vidmer Scaioli², Eliana Mauri², Andrea Salmaggi²

Affiliations

¹ Neurology Unit, Ospedale A. Manzoni, ASST Lecco, Via Dell'Eremo 9-11, 23900, Lecco, Italy. rig74@libero.it.
² Neurology Unit, Ospedale A. Manzoni, ASST Lecco, Via Dell'Eremo 9-11, 23900, Lecco, Italy.

PMID: 38926246
DOI: 10.1007/s10072-024-07663-w

No abstract available

Publication types

Letter
Case Reports

MeSH terms

Adult
Antibodies, Monoclonal, Humanized* / pharmacology
Antibodies, Monoclonal, Humanized* / therapeutic use
Biomarkers
Complement Inactivating Agents / pharmacology
Complement Inactivating Agents / therapeutic use
Electric Stimulation
Electromyography*
Female
Humans
Male
Middle Aged
Myasthenia Gravis* / diagnosis
Myasthenia Gravis* / drug therapy
Myasthenia Gravis* / physiopathology

Substances

Antibodies, Monoclonal, Humanized
eculizumab
Biomarkers
Complement Inactivating Agents